TLRY
IGC overvalued, SHORT IGC is another cannabis stock that soared way too fast based on no tangible numbers. The Cannabis market will be a big market for sure. But the energy beverage sector is extremely competitive; we would have to see how the "Nitro G" can compete before the stock soars 1000% in a couple days. This is definitely the pumping phase, and it will come down.
TILRAY - Technical AnalysisDear Traders,
We can see that TLRY has broken out but without big volume (which I expect, to be honest).
I think most Traders/Bots are waiting for the MACD to cross upwards signal before creating another run-up.
Let's see how this plays out.
If you enter, don't forget your stop loss.
About TILRAY:
Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. Its products include dried cannabis and cannabis extracts. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.
Latest news:
www.fool.com
Kalytera - Technical AnalysisDear Traders,
As we can see KALY is retracing, the idea is to find our next entry point.
Have a look at the green circle, that 50 fib level might be our point of interest.
About Kalytera Therapeutics
Kalytera Therapeutics, Inc. ("Kalytera") is pioneering the development of a next generation of cannabinoid therapeutics. Through its proven leadership, drug development expertise, and intellectual property portfolio, Kalytera seeks to establish a leading position in the development of novel cannabinoid medicines for a range of important unmet medical needs, with an initial focus on graft versus host disease (“GVHD”) .
Kalytera also intends to develop a new class of proprietary cannabidiol ("CBD") therapeutics. CBD is a versatile compound that has shown activity against a number of pharmacological targets. However, there are limitations associated with natural CBD, including its poor oral bioavailability. Kalytera will seek to develop innovative CBD formulations and prodrugs in an effort to overcome these limitations, and to target specific disease sites within the body. Kalytera intends to file composition of matter and method of use patents covering its novel inventions, with the goal of limiting future competition.
Website Home: kalytera.co
News and Insights: kalytera.co
Investors: kalytera.co
TGOD - Technical Analysis - Reversal Point reached ?Here is my TA for TGOD, did it reach a reversal point ?
As you can see we are still in a bearisch channel but as soon as the bulls manage to breakout, we will have a bullish mood again with more volume.
17 october (Legalisation of marijuana in Canada) is getting closer, I can't wait to see what will happen.
What are you're thougts ?
ABBVIE - Technical AnalysisDear Traders,
ABBVIE looks to be on the edge for a breakout, the MACD shows a Bullish Hidden Divergence which backs-up my LONG position.
Any thoughts ?
About Abbvie:
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the discovery, development, manufacture and sale of a line of proprietary pharmaceutical products. It is focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.
GWPH - Technical AnalysisDear Traders,
GWPH, also known as GGW Pharmaceuticals plc (GWPH), has been following its bullish Channel pretty well. Thos I don't really know if im Bullish or Berish for now. We have good volume, we are in a bullish channel, but we are under the 1H 55 ema (Blue line). If resistance at the 55 ema holds, we will see a bit more retracing, but if we succeed in buying that resistance, i'll be 100% bullish.
About GWPH :
GW Pharmaceuticals plc researches and develops cannabinoid prescription medicines for the treatment of cancer pain, Multiple Sclerosis, and neuropathic pain.
Latest News:
finance.yahoo.com
Canopy Rivers Inc - Technical AnalysisDear traders,
Here is my TA for Canopy Rivers Inc,
We find ourselves in a downtrend channel from which we need to brake out in order to change the mood.
With the MACD Continuing Divergence, which is a Bullish sign, we now need to see higher lows and lower lows in order to breakout from this channel.
What is you're opinion on this stock ?
Integrated Cannabis Company - Technical AnalysisDear traders,
Last week Integrated Cannabis Company announced the completion of a Letter Agreement to collaborate on X-SPRAYSTM products for the Canadian market with a Canadian License Producer under Health Canada's Access to Cannabis for Medical Purposes Regulations, GTEC Holdings Ltd. Friday the company's stock saw its most active day since going public and during pre-market trading on Monday (10/1/2018), shares of Integrated Cannabis have traded as high as $1.16.
"Partnering with a Canadian Licensed Producer has been a major goal of ours in order to facilitate the expansion of our product line into legal, established marketplaces. The GTEC team is an ideal partner given their status asa LP and their tenure in the cannabis industry and provide a great alliance for our innovative product line," said Mr. John Knapp, CEO of Integrated Cannabis.
Integrated Cannabis Company (ICNAF) (ICAN) has seen its most active trading week in history of being public (so far). Shares opened the week at $1.1665 and hit highs on Tuesday of $1.43.
What are you thoughts about this TA ?
Aurora - Technical AnalysisDear Traders,
Looks like we enterred a second ''bearish'' tunnel, but if we succeed in breaking out of it like we did the first time we might see another run soon. But if we break downwards we will officially retracing towards the 0.5 fib level again, which held twice already so that looks like a good entry point for those who want to re-enter this trade, but this will only happen if we break downwards of this channel.
About Aurora:
Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in more than 18 countries worldwide.
DTEA, Nice HIgh Risk High Reward GambleGoes completely against my rules, but with the way this sector is moving, and considering how much money people have made off IGC and NBEV, this thing has a high chance of following through tomorrow.
Also, this stock only has 7 million in the float. Also, a big seller cashed out!!!!!!!! I haven't had time to check warrants, but judging from the price last year, I'm guessing they are not going to be lower than the current price.
THIS IS A GAMBLE, BUT A GOOD ONE
DO NOT BET THE RANCH, BUT DON'T SELL YOURSELF SHORT EITHER
GOOD LUCK
Leading TLRY analyst reporting for duty - YoungShkreli up 30%!Hello friends,
We are up about 30% from the point I went long. Read about that here: .
Same as before friends, I am expecting to go to the $180 region which would represent about a 40% return in a week for those who followed my advice. Do not be surprised is TLRY makes a new all time high. The other day it had the most trading volume on the entire stock exchange. This bad boy has monaaaay going through it. I'm not saying it's smart money, but it is money and this means volatility is guaranteed. Do not short at this time.
Good luck!
-YoungShkreli
Tilray updateHello everyone,
That green line is there from the last time. I was expecting to retrace to this level, and we have. The powers of a good strategy are too great.
Not recommending a buy yet. Stay tuned, folks. I doubt this is the death of Tilray :).
Flashback to bitcoin: short in december when the ETF is released (I don't know if this will happen, would be funny though lol)
-YoungShkreli
TLRY - Pump, Dump, RepeatTilray's recent bubble pop has a lot of shareholders in panic mode. Despite the massive spread and a 60% drop from the high in just two days, an incredible amount of speculation still remains in the cannabis sector. What makes TLRY different than other cannabis stocks is the incredibly low float of ~18M shares, which serves to amplify the effects of speculative trading (in both directions). Compare the float to the average daily volume of 9M shares, and you will see what I mean.
TLRY touched the 38.2% fib level after market Friday, and according to the 5/26 MACD has some room left to drop. I set my fibonacci bounds to the high near $300, and low at listing price around $20. It is difficult to tell how far down something this volatile will go, but according to the setup we can expect a bounce around the $60-$80 price range (likewise, when the 26-EMA touches $100, a previous support/resistance level). There will likely be a mini-bounce around $100 but I do not count on it sticking. 5/26 MACD indicates we have at least a few days before this thing will start to find a bottom.
Implied volatility will be crushed as standard deviation reduces from the averaging of pump and dump outliers, which will in turn lower option premiums. Planning to buy some covered calls if the setup bites, otherwise reassessment will be necessary. Worst case scenario for this setup is that it hits the $60-$80 range and flattens, crushing option premium even further (which can be mitigated through use of covered calls combined with put credit spreads if necessary).
Recreational legalization in Canada on Oct. 17th along with TLRY being the first Canadian cannabis company to obtain operational license within the U.S. add fuel to the fire that is speculation. Also of note is the disruptive impact that cannabis companies will have on traditional pharmaceuticals, a market holding ~$1.1T capitalization. There is also the potential for more states to legalize cannabis for either recreational/medical use. These all fuel speculative interactions within the market.
A note on long term TLRY trades: there are 10M+ shares in lockup until January 2019, which will become public sometime then. I do not suggest holding any positions into January as the market will likely react violently to the increase in float.
YoungShkreli said to wait to buy and was right... what now?Hello friends,
I got way more views on my coverage of a stock than I thought I would. In my last post, I said I would be looking to short this stock. So far anyone who went short is up a lot of money.
I am expecting to fall to the line I have drawn. I will let you know when a buying opportunity comes. For now, if you are wanting to buy, you must wait. Do not short this stock from here and for the love of God, don't short without a stop loss. You will lose EVERYTHING if you short without a stop in the long run. Let this be your warning.
I am trying to make it to the top of the active daily traders page today. Check out my work, you will see I do pretty damn well. Please help me to achieve this goal, it will help all of you who want to become a successful trader.
I do not need to do these and if I am not successful, I will stop. If you value my work, you need to follow me and like my work if you want me to remain here.
Get on it, people!
-YoungShkreli